Try our beta test site
881 studies found for:    Open Studies | "Carcinoma, Bronchogenic"
Show Display Options
Rank Status Study
21 Recruiting Study to Investigate the Absorption, Metabolism and Excretion of [14C] AC0010 in Patients With Advanced NSCLC
Condition: Carcinoma, Non-Small-Cell Lung
Intervention: Drug: 14C-labeled AC0010 oral
22 Not yet recruiting Combination Study of Guadecitabine and Pembrolizumab.
Conditions: Castration-Resistant Prostatic Cancer;   Non Small Cell Lung Cancer
Interventions: Drug: Guadecitabine;   Drug: Pembrolizumab
23 Recruiting Single-port, Two-port Versus Three-port VATS on Non-small Cell Lung Cancer
Condition: Lung Neoplasm
Interventions: Procedure: Three-port pulmonary resection surgery;   Procedure: Single-port or two-port surgery
24 Not yet recruiting EGFR-TKI Resistance Profile in Chinese Patients With Advanced EGFRm+ NSCLC
Condition: Nonsmall Cell Lung Cancer
Intervention:
25 Recruiting A Phase II Study of Fruquintinib in Combination With Gefitinib in Patients With Advanced Non-small Cell Lung Cancer
Condition: NSCLC
Interventions: Drug: Fruquintinib;   Drug: Gefitinib
26 Not yet recruiting Phase II Trial of SBRT Compared With Conventional Radiotherapy for Oligometastatic Non-Small Cell Lung Cancer
Condition: NSCLC
Interventions: Radiation: Conventional Fractionated Radiotherapy;   Radiation: Stereotactic Body Radiation Therapy
27 Not yet recruiting Safety, Tolerability, Pharmacokinetics and Anti-tumour Activity of Alflutinib in Advanced Non Small Cell Lung Cancer
Condition: NSCLC
Intervention: Drug: Alflutinib
28 Recruiting Extensive Stage Sclc Patients Who Were Benefit From First-line Treatment Accept Temozolomide Maintain Therapeutic
Condition: Extensive Stage Small Cell Lung Cancer
Intervention: Drug: temozolomide
29 Recruiting Study of ASN003 in Subjects With Advanced Solid Tumors
Conditions: Neoplasms;   Melanoma;   Colorectal Neoplasm;   Carcinoma, Non-small Cell Lung
Interventions: Drug: ASN003 ascending doses;   Drug: ASN003 MTD
30 Recruiting High-dose Icotinib Treatment Beyond Progression in EGFR Mutant NSCLC
Condition: Carcinoma, Non-Small-Cell Lung
Intervention: Drug: Icotinib
31 Recruiting Osimertinib or Docetaxel-bevacizumab as Third-line Treatment in EGFR T790M Mutated Non-Small Cell Lung Cancer
Condition: Progression Free Survival
Interventions: Drug: Osimertinib;   Drug: docetaxel, bevacizumab
32 Recruiting Phase 2 Study of Glesatinib, Sitravatinib or Mocetinostat in Combination With Nivolumab in Non-Small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: Glesatinib;   Drug: Sitravatinib;   Drug: Mocetinostat;   Drug: Nivolumab
33 Not yet recruiting Combination of Platinum Doublets and Hypofractionated Radiotherapy in NSCLC
Condition: Non-Small Cell Lung Cancer
Interventions: Drug: Cisplatin;   Radiation: hypofractionated radiotherapy;   Drug: Pemetrexed;   Drug: Etoposide
34 Recruiting Bevacizumab in the Treatment of Malignant Pleural Effusions of Non-squamous Non-small Cell Lung Cancer
Condition: Malignant Pleural Effusion
Intervention: Drug: Bevacizumab
35 Not yet recruiting Gefitinib Combined With Chemotherapy or Antiangiogensis in Patients With Bim Deletion or Low EGFR Mutation Abundance
Condition: Non-small-cell Lung Cancer
Interventions: Drug: Gefitinib;   Drug: pemetrexed or gemcitabine plus carboplatin,;   Drug: bevacizumab
36 Not yet recruiting Safety, Efficacy and Pharmacokinetic of BPI-9016M in Patients With c-Met- Dysregulated Advanced NSCLC
Condition: Non-small Cell Lung Cancer
Intervention: Drug: BPI-9016M
37 Recruiting Trial of Dose Escalated BGB324 in Previously Treated Non-small Cell Lung Cancer.
Condition: Non-Small Cell Lung Carcinoma
Interventions: Drug: BGB324;   Drug: Docetaxel
38 Not yet recruiting Detection of Circulating Biomarkers of Immunogenic Cell Death
Condition: Non Small Cell Lung Cancer
Intervention: Other: Blood withdrawal
39 Not yet recruiting Study of Paclitaxel, Carboplatin, and PF-05212384 in Advanced or Metastatic NSCLC (UF-STO-LUNG-002)
Condition: Non-Small Cell Lung Cancer
Interventions: Drug: Gedatolisib;   Drug: Paclitaxel;   Drug: Carboplatin
40 Not yet recruiting Effect of Different Anesthetics on the Change of Alarmins in Lung Cancer Patients Receiving Pulmonary Lobectomy
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: Sevoflurane;   Drug: Propofol

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.